Morgan Stanley’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $341K | Buy |
84,781
+465
| +0.6% | +$1.87K | ﹤0.01% | 5636 |
|
|
2025
Q1 | $293K | Buy |
84,316
+9,488
| +13% | +$32.9K | ﹤0.01% | 5575 |
|
|
2024
Q4 | $492K | Sell |
74,828
-167,000
| -69% | -$1.1M | ﹤0.01% | 5422 |
|
|
2024
Q3 | $2.19M | Buy |
241,828
+229,165
| +1,810% | +$2.07M | ﹤0.01% | 4586 |
|
|
2024
Q2 | $203K | Sell |
12,663
-1,281
| -9% | -$20.5K | ﹤0.01% | 5668 |
|
|
2024
Q1 | $219K | Sell |
13,944
-5,032
| -27% | -$78.9K | ﹤0.01% | 5705 |
|
|
2023
Q4 | $255K | Buy |
+18,976
| New | +$255K | ﹤0.01% | 5856 |
|